SequelSEC

Vicarious Surgical Inc. RBOT

Orthopedic, Prosthetic & Surgical Appliances & Supplies · CIK 0001812173 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
Unavailable
Fiscal year ended 2025-12-31
Operating income
-$50.03M
Fiscal year ended 2025-12-31
Free cash flow
-$45.21M
Fiscal year ended 2025-12-31

Vicarious Surgical Inc. (RBOT) reported net income of -$50.18M for the fiscal year ended 2025-12-31. This page shows 6 annual periods of income statement, balance sheet and cash flow figures normalized from Vicarious Surgical Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Orthopedic, Prosthetic & Surgical Appliances & Supplies.

Income

Vicarious Surgical Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
RevenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating income-$50.03M-$66.56M-$80.67M-$80.08M-$38.22M-$12.98M
Net income-$50.18M-$63.22M-$71.07M$5.16M-$35.21M-$12.88M
Research & development$33.60M$40.16M$47.58M$43.90M$22.06M$9.80M
Weighted-average diluted sharesshares 6.13Mshares 5.89Mshares 4.87Mshares 127.53Mshares 96.69Mshares 78.74M
Pretax income-$50.18M-$63.22M-$71.07M$5.16M-$35.21M-$12.88M
Income tax expenseUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Diluted EPSUnavailableUnavailable$-0.49$0.04$-0.36$-0.16
Selling, general & administrative$17.37M$26.40M$33.09M$36.18M$16.16M$3.19M
General & administrative$15.20M$21.88M$26.86M$29.72M$13.20M$2.33M
Selling & marketing$2.17M$4.52M$6.23M$6.46M$2.96M$861.00K

Balance

Vicarious Surgical Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Cash & equivalents$2.57M$9.74M$52.82M$116.21M$173.51M$16.87M
Total assets$19.58M$67.72M$119.86M$140.29M$181.68M$17.79M
Current assets$11.58M$51.70M$100.95M$120.40M$178.37M$17.12M
Total liabilities$9.74M$21.02M$21.90M$29.25M$98.59M$935.00K
Current liabilities$3.90M$7.67M$7.28M$8.39M$6.24M$814.00K
Total equity incl. NCI$9.84M$46.70M$97.97M$111.04M$83.09M-$29.82M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailable$299.80M
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailable$2.00MUnavailable$675.00KUnavailable
Accounts payable$894.00K$1.17M$1.26M$1.73M$1.50M$373.00K

Cash flow

Vicarious Surgical Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Operating cash flow-$45.08M-$49.96M-$62.30M-$61.21M-$33.30M-$12.04M
Capital expenditures$132.00K$180.00K$1.67M$5.35M$1.29M$120.00K
Investing cash flow$32.15M$6.86M-$45.78M-$5.35M-$1.29M$13.20M
Financing cash flow$5.76M$8.00K$44.70M$9.14M$192.16M$13.52M
Net change in cashUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Stock-based compensation$8.14M$11.90M$13.27M$12.26M$3.69M$448.00K
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Derived

Vicarious Surgical Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Free cash flow-$45.21M-$50.14M-$63.98M-$66.56MUnavailable-$12.16M
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current ratio2.97x6.74x13.87x14.35x28.56x21.04x
Revenue YoY growthUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Net marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open RBOT in the interactive workspace to inspect any figure back to its filing.

Source filings

10-K · Filed 2026-03-09View SEC filing
10-Q · Filed 2025-11-12View SEC filing
10-Q · Filed 2025-08-12View SEC filing
10-Q · Filed 2025-05-12View SEC filing
10-K · Filed 2025-03-17View SEC filing
10-Q · Filed 2024-11-12View SEC filing

Companies in the same industry

ALGN APT AVR BBLG CDRE COCH ENOV ESTA EW FEED INGN ISRG

Reconciliation checks needing review

1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

balance equationreview2020-12-31

Difference 253134680 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.